Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMEDIC from Assesse, company number BE0715682133, closed financial year 2025 with a result of € 54,336 after tax. For that financial year PHARMEDIC recorded a gross margin of € 223,924 and equity of € 129,921. Compared with financial year 2024, the result moved from € 18,777 to € 54,336. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 129,921
▲ 72% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 54,336
▲ 189% vs 2024
Profit after tax over the fiscal year.
€ 57,121
▼ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 111,321.
People and assets in 2025
€ 34,009
▲ 17% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 41,176
▼ 30% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 880,168
▼ 8% vs 2024
€ 70,429 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 47,536
▲ 131% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,109
▲ 91% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 115,994 | € 179,884 | € 162,418 | € 223,924 | ▲ 38% |
| Profit after taxes | € 10,286 | € 1,594 | € 18,777 | € 54,336 | ▲ 189% |
| Equity | € 55,214 | € 56,808 | € 75,585 | € 129,921 | ▲ 72% |
| Total debts | € 127,950 | € 1,238,196 | € 1,213,370 | € 1,154,776 | ▼ 5% |
| Cash | € 3,306 | € 117,486 | € 100,486 | € 57,121 | ▼ 43% |
| Land & buildings | - | € 721,213 | € 702,345 | € 709,016 | ▲ 1% |
| Retained profit | € 36,614 | € 38,208 | € 56,985 | € 111,321 | ▲ 95% |
| Bank debt | € 23,863 | € 966,168 | € 953,587 | € 880,168 | ▼ 8% |
| Balance sheet total | € 183,165 | € 1,295,005 | € 1,288,955 | € 1,284,697 |
Key figures of PHARMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMEDIC?
What happened at PHARMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 54,336 (▲ 189% vs 2024). filed late Source: NBB ↗
- New establishment in Assesse. KBO
- New establishment in Fernelmont. KBO
- New establishment in La Bruyère. KBO
- Start of the company according to the CBE. KBO
In short
From € 10,286 profit in 2022 to € 54,336 profit in 2025.
Paid € 15,037 in corporate taxes since 2022.
Best year ever: 2025, with € 54,336 profit.
Establishments
Establishment units
Physical locations of this company
Rue du Fays 1
5336 Assesse
Chaussée d'Eghezée, Meux 46
5081 La Bruyère
Active since 11 December 2018
Rue des Cortys, Hempt. 12
5380 Fernelmont
Active since 1 December 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0715.682.133
- VAT number
- BE 0715.682.133
- Registered office
- Rue du Fays 1, 5336 Assesse
- Names & denominations
- PHARMEDIC · STEEL & MORE / PHARMACOURRIERE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 December 2018
- Peppol
- Active · Active since 18 Jan 2026
- Contact
- [email protected] +32474860277
- Activities · NACE
Detailhandel in farmaceutische producten
Smeden van metaal